Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (55)
Mingzhu Cao, Zhi Liu, Danming You, Yingying Pan & Qingyan Zhang. (2023) TMT-based quantitative proteomic analysis of spheroid cells of endometrial cancer possessing cancer stem cell properties. Stem Cell Research & Therapy 14:1.
Crossref
Crossref
Zhaorui Miao, Qianhua Cao, Ruocen Liao, Xingyu Chen, Xiaoli Li, Longchang Bai, Chenglong Ma, Xinyue Deng, Zhijun Dai, Jun Li & Chenfang Dong. (2022) Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Elisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, Isolda Casanova, Alberto Gallardo, Ugutz Unzueta, Naroa Serna, Laura Sánchez-García, Miquel Quer, Antonio Villaverde, Esther Vázquez, Ramon Mangues, Lorena Alba-Castellón & Xavier León. (2022) Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors. Acta Pharmaceutica Sinica B 12:5, pages 2578-2591.
Crossref
Crossref
Esther N. Pijnappel, Nienke P. M. Wassenaar, Oliver J. Gurney-Champion, Remy Klaassen, Koen van der Lee, Marjolein C. H. Pleunis-van Empel, Dick J. Richel, Marie C. Legdeur, Aart J. Nederveen, Hanneke W. M. van Laarhoven & Johanna W. Wilmink. (2021) Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer. Cancers 13:19, pages 4869.
Crossref
Crossref
Shenq-Shyang Huang, Wen-Ying Liao, Chung-Chi Hsu, Tze-Sian Chan, Tai-Yan Liao, Pei-Ming Yang, Li-Tzong Chen, Shian-Ying Sung & Kelvin K. Tsai. (2021) A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells. Frontiers in Oncology 11.
Crossref
Crossref
Marina Elena Cazzaniga, Nicoletta Cordani, Serena Capici, Viola Cogliati, Francesca Riva & Maria Grazia Cerrito. (2021) Metronomic Chemotherapy. Cancers 13:9, pages 2236.
Crossref
Crossref
Shi Chen, Long Huang, Ge Li, Funan Qiu, Yaodong Wang, Can Yang, Jingjing Pan, Zhangwei Wu, Jiangzhi Chen & Yifeng Tian. (2020) LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression. Clinical Epigenetics 12:1.
Crossref
Crossref
Dongyeob Seo, Su Myung Jung, Jin Seok Park, Jaewon Lee, Jihoon Ha, Minbeom Kim & Seok Hee Park. (2019) The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway. eBioMedicine 49, pages 55-71.
Crossref
Crossref
Ming‐Cheng Chen, Rathinasamy Baskaran, Nien‐Hung Lee, Hsi‐Hsien Hsu, Tsung‐Jung Ho, Chuan‐Chou Tu, Yueh‐Min Lin, Vijaya Padma Viswanadha, Wei‐Wen Kuo & Chih‐Yang Huang. (2018) CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT‐11‐resistant LoVo colon cancer cells via Gαi‐2 and Gαq/11. Journal of Cellular Physiology 234:7, pages 11822-11834.
Crossref
Crossref
Rongxuan Zhu, Olivier Gires, Liqun Zhu, Jun Liu, Junjian Li, Hao Yang, Gaoda Ju, Jing Huang, Weiyu Ge, Yi Chen, Zhimin Lu & Hongxia Wang. (2019) TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling. Nature Communications 10:1.
Crossref
Crossref
Kelvin K. Tsai, Tze-Sian Chan & Yuval Shaked. (2019) Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks. Journal of Clinical Medicine 8:5, pages 702.
Crossref
Crossref
Amit K. Srivastava, Ananya Banerjee, Tiantian Cui, Chunhua Han, Shurui Cai, Lu Liu, Dayong Wu, Ri Cui, Zaibo Li, Xiaoli Zhang, Guozhen Xie, Karuppaiyah Selvendiran, Srinivas Patnaik, Adam R. Karpf, Jinsong Liu, David E. Cohn & Qi-En Wang. (2019) Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer. Cancer Research 79:9, pages 2314-2326.
Crossref
Crossref
Dimitra Manou, Ilaria Caon, Panagiotis Bouris, Irene-Eva Triantaphyllidou, Cristina Giaroni, Alberto Passi, Nikos K. Karamanos, Davide Vigetti & Achilleas D. Theocharis. 2019. The Extracellular Matrix. The Extracellular Matrix
1
20
.
Tiantian Cui, Amit Kumar Srivastava, Chunhua Han, Dayong Wu, Nissar Wani, Lu Liu, Zhiqin Gao, Meihua Qu, Ning Zou, Xiaoli Zhang, Ping Yi, Jianhua Yu, Erica H. Bell, Shyh-Ming Yang, David J. Maloney, Yanfang Zheng, Altaf A. Wani & Qi-En Wang. (2018) DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1. Cell Death & Disease 9:5.
Crossref
Crossref
Amit Kumar Srivastava, Asim Rizvi, Tiantian Cui, Chunhua Han, Ananya Banerjee, Imrana Naseem, Yanfang Zheng, Altaf A. Wani & Qi-En Wang. (2018) Depleting ovarian cancer stem cells with calcitriol. Oncotarget 9:18, pages 14481-14491.
Crossref
Crossref
Mohini Singh, Nicolas Yelle, Chitra Venugopal & Sheila K. Singh. (2018) EMT: Mechanisms and therapeutic implications. Pharmacology & Therapeutics 182, pages 80-94.
Crossref
Crossref
Sham S. Kakar, Seema Parte, Kelsey Carter, Irving G. Joshua, Christopher Worth, Pranela Rameshwar & Mariusz Z. Ratajczak. (2017) Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells. Oncotarget 8:43, pages 74494-74505.
Crossref
Crossref
Aparna Kalyan, Benedito A. Carneiro, Sunandana Chandra, Jason Kaplan, Young Kwang Chae, Maria Matsangou, Mary J.C. Hendrix & Francis Giles. (2017) Nodal Signaling as a Developmental Therapeutics Target in Oncology. Molecular Cancer Therapeutics 16:5, pages 787-792.
Crossref
Crossref
P. Martinelli & E. Lonardo. 2017. Introduction to Cancer Metastasis. Introduction to Cancer Metastasis
117
135
.
Lukas Perkhofer, Karolin Walter, Ivan G. Costa, Maria C. Romero Carrasco, Tim Eiseler, Susanne Hafner, Felicitas Genze, Martin Zenke, Wendy Bergmann, Anett Illing, Meike Hohwieler, Ralf Köhntop, Qiong Lin, Karl-Heinz Holzmann, Thomas Seufferlein, Martin Wagner, Stefan Liebau, Patrick C. Hermann, Alexander Kleger & Martin Müller. (2016) Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Stem Cell Research 17:2, pages 367-378.
Crossref
Crossref
Silvia Lemma, Sofia Avnet, Manuela Salerno, Tokuhiro Chano & Nicola Baldini. (2016) Identification and Validation of Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells. PLOS ONE 11:2, pages e0149481.
Crossref
Crossref
Hyewon ChungYu-Hwan KimMyoung KwonSo-Jin ShinSang-Hoon KwonSoon-Do ChaChi-Heum Cho. (2016) The effect of salinomycin on ovarian cancer stem-like cells. Obstetrics & Gynecology Science 59:4, pages 261.
Crossref
Crossref
Zhengfeng Yin. 2016. Hepatocellular Carcinoma. Hepatocellular Carcinoma
167
197
.
Mark I. James, Lynne M. Howells, Ankur Karmokar, Jennifer A. Higgins, Peter Greaves, Hong Cai, Ashley Dennison, Matthew Metcalfe, Giuseppe Garcea, David M. Lloyd, David P. Berry, William P. Steward & Karen Brown. (2015) Characterization and Propagation of Tumor Initiating Cells Derived from Colorectal Liver Metastases: Trials, Tribulations and a Cautionary Note. PLOS ONE 10:2, pages e0117776.
Crossref
Crossref
Sham S. Kakar, Mariusz Z. Ratajczak, Karen S. Powell, Mana Moghadamfalahi, Donald M. Miller, Surinder K. Batra & Sanjay K. Singh. (2014) Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells. PLoS ONE 9:9, pages e107596.
Crossref
Crossref
A. Kleger, L. Perkhofer & T. Seufferlein. (2014) Smarter drugs emerging in pancreatic cancer therapy. Annals of Oncology 25:7, pages 1260-1270.
Crossref
Crossref
Chunhua Han, Ran Zhao, Xingluo Liu, Amit Srivastava, Li Gong, Hsiaoyin Mao, Meihua Qu, Weiqiang Zhao, Jianhua Yu & Qi-En Wang. (2014) DDB2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer. Molecular Cancer Research 12:5, pages 784-794.
Crossref
Crossref
Kohei Sano, Ryo Masuda, Hayato Hisada, Shinya Oishi, Kenta Shimokawa, Masahiro Ono, Nobutaka Fujii, Hideo Saji & Takahiro Mukai. (2014) A radiogallium–DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. Bioorganic & Medicinal Chemistry Letters 24:5, pages 1386-1388.
Crossref
Crossref
V. Heinemann, M. Reni, M. Ychou, D.J. Richel, T. Macarulla & M. Ducreux. (2014) Tumour?stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies. Cancer Treatment Reviews 40:1, pages 118-128.
Crossref
Crossref
Anke Van den broeck, Hugo Vankelecom, Wouter Van Delm, Lies Gremeaux, Jasper Wouters, Joke Allemeersch, Olivier Govaere, Tania Roskams & Baki Topal. (2013) Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes. PLoS ONE 8:9, pages e73968.
Crossref
Crossref
X Zheng, J Naiditch, M Czurylo, C Jie, T Lautz, S Clark, N Jafari, Y Qiu, F Chu & M B Madonna. (2013) Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics. Cell Death & Disease 4:7, pages e740-e740.
Crossref
Crossref
Dongqing Wang, Haitao Zhu, Ying Zhu, Yanfang Liu, Huiling Shen, Ruigen Yin, Zhijian Zhang & Zhaoliang Su. (2013) RETRACTED: CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Acta Histochemica 115:4, pages 349-356.
Crossref
Crossref
Susana García-Silva, Javier Frias-Aldeguer & Christopher Heeschen. (2013) Stem cells & pancreatic cancer. Pancreatology 13:2, pages 110-113.
Crossref
Crossref
Yu Zhang, Jun Li, Lu Cao, Wen Xu & Zhengfeng Yin. (2012) Circulating Tumor Cells in Hepatocellular Carcinoma: Detection Techniques, Clinical Implications, and Future Perspectives. Seminars in Oncology 39:4, pages 449-460.
Crossref
Crossref
Andreas E. Albers, Chao Chen, Beate Köberle, Xu Qian, Jens P. Klussmann, Barbara Wollenberg & Andreas M. Kaufmann. (2012) Stem cells in squamous head and neck cancer. Critical Reviews in Oncology/Hematology 81:3, pages 224-240.
Crossref
Crossref
Rodolfo Molina-Peña & Mario Moisés Álvarez. (2012) A Simple Mathematical Model Based on the Cancer Stem Cell Hypothesis Suggests Kinetic Commonalities in Solid Tumor Growth. PLoS ONE 7:2, pages e26233.
Crossref
Crossref
Zhizhong Li. 2012. Stem Cells and Human Diseases. Stem Cells and Human Diseases
581
591
.
Shi-Long Lu. 2012. Stem Cells and Human Diseases. Stem Cells and Human Diseases
497
507
.
A. Ugur Ural. 2012. Adult and Embryonic Stem Cells. Adult and Embryonic Stem Cells
227
235
.
Francesca Casagrande, Emiliano Cocco, Stefania Bellone, Christine E. Richter, Marta Bellone, Paola Todeschini, Eric Siegel, Joyce Varughese, Dan Arin‐Silasi, Masoud Azodi, Thomas J. Rutherford, Sergio Pecorelli, Peter E. Schwartz & Alessandro D. Santin. (2011)
Eradication of chemotherapy‐resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of
clostridium perfringens
enterotoxin
. Cancer 117:24, pages 5519-5528.
Crossref
Crossref
Enza Lonardo, Patrick C. Hermann, Maria-Theresa Mueller, Stephan Huber, Anamaria Balic, Irene Miranda-Lorenzo, Sladjana Zagorac, Sonia Alcala, Iker Rodriguez-Arabaolaza, Juan Carlos Ramirez, Raul Torres-Ruíz, Elena Garcia, Manuel Hidalgo, David Álvaro Cebrián, Rainer Heuchel, Matthias Löhr, Frank Berger, Peter Bartenstein, Alexandra Aicher & Christopher Heeschen. (2011) Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy. Cell Stem Cell 9:5, pages 433-446.
Crossref
Crossref
Ryo Masuda, Shinya Oishi, Hiroaki Ohno, Hiroyuki Kimura, Hideo Saji & Nobutaka Fujii. (2011) Concise site-specific synthesis of DTPA–peptide conjugates: Application to imaging probes for the chemokine receptor CXCR4. Bioorganic & Medicinal Chemistry 19:10, pages 3216-3220.
Crossref
Crossref
Hangwen Li & Dean G. Tang. (2011) Prostate cancer stem cells and their potential roles in metastasis. Journal of Surgical Oncology 103:6, pages 558-562.
Crossref
Crossref
Shailaja Akunuru, Joseph Palumbo, Qihui James Zhai & Yi Zheng. (2011) Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity. PLoS ONE 6:2, pages e16951.
Crossref
Crossref
Olga Gaidarenko & Yang Xu. 2011. Cancer Stem Cells in Solid Tumors. Cancer Stem Cells in Solid Tumors
209
222
.
Anatoly V. Lichtenstein. (2010) Cancer: evolutionary, genetic and epigenetic aspects. Clinical Epigenetics 1:3-4, pages 85-100.
Crossref
Crossref
Enza Lonardo, Patrick C. Hermann & Christopher Heeschen. (2010) Pancreatic cancer stem cells – update and future perspectives. Molecular Oncology 4:5, pages 431-442.
Crossref
Crossref
Murielle Mimeault, Sonny L. Johansson, Shantibhusan Senapati, Navneet Momi, Subhankar Chakraborty & Surinder K. Batra. (2010) MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letters 295:1, pages 69-84.
Crossref
Crossref
C. Maenhaut, J.E. Dumont, P.P. Roger & W.C.G. van Staveren. (2010) Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31:2, pages 149-158.
Crossref
Crossref
Thomas Seufferlein, Johann Ahn, Denis Krndija, Ulrike Lother, Guido Adler & Götz von Wichert. (2009) Tumor biology and cancer therapy – an evolving relationship. Cell Communication and Signaling 7:1.
Crossref
Crossref
Maria–Theresa Mueller, Patrick C. Hermann, Juliane Witthauer, Belen Rubio–Viqueira, Simon F. Leicht, Stephan Huber, Joachim W. Ellwart, Mona Mustafa, Peter Bartenstein, Jan G. D'Haese, Michael H. Schoenberg, Frank Berger, Karl–Walter Jauch, Manuel Hidalgo & Christopher Heeschen. (2009) Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer. Gastroenterology 137:3, pages 1102-1113.
Crossref
Crossref
A. V. Lichtenstein. (2009) Carcinogenesis: Evolution of concepts. Biochemistry (Moscow) 74:4, pages 353-361.
Crossref
Crossref
Zhuo (Georgia) Chen. (2009) The Cancer Stem Cell Concept in Progression of Head and Neck Cancer. Journal of Oncology 2009, pages 1-8.
Crossref
Crossref
Leah Owens, Benjamin Tiede & Yibin Kang. 2009. Stem Cells and Cancer. Stem Cells and Cancer
91
109
.
Alexei V. Salnikov, Jury Gladkich, Gerhard Moldenhauer, Manfred Volm, J��rgen Mattern & Ingrid Herr. (2009) CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. International Journal of Cancer, pages NA-NA.
Crossref
Crossref